全文获取类型
收费全文 | 1501篇 |
免费 | 115篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 60篇 |
妇产科学 | 42篇 |
基础医学 | 290篇 |
口腔科学 | 23篇 |
临床医学 | 155篇 |
内科学 | 374篇 |
皮肤病学 | 17篇 |
神经病学 | 113篇 |
特种医学 | 18篇 |
外科学 | 148篇 |
综合类 | 16篇 |
预防医学 | 164篇 |
眼科学 | 33篇 |
药学 | 86篇 |
中国医学 | 1篇 |
肿瘤学 | 73篇 |
出版年
2023年 | 8篇 |
2022年 | 19篇 |
2021年 | 31篇 |
2020年 | 16篇 |
2019年 | 19篇 |
2018年 | 31篇 |
2017年 | 15篇 |
2016年 | 34篇 |
2015年 | 39篇 |
2014年 | 45篇 |
2013年 | 56篇 |
2012年 | 71篇 |
2011年 | 99篇 |
2010年 | 55篇 |
2009年 | 55篇 |
2008年 | 92篇 |
2007年 | 76篇 |
2006年 | 74篇 |
2005年 | 90篇 |
2004年 | 80篇 |
2003年 | 86篇 |
2002年 | 80篇 |
2001年 | 36篇 |
2000年 | 38篇 |
1999年 | 39篇 |
1998年 | 19篇 |
1997年 | 18篇 |
1996年 | 13篇 |
1995年 | 11篇 |
1994年 | 10篇 |
1993年 | 10篇 |
1992年 | 20篇 |
1991年 | 15篇 |
1990年 | 25篇 |
1989年 | 9篇 |
1988年 | 13篇 |
1987年 | 18篇 |
1986年 | 13篇 |
1985年 | 16篇 |
1984年 | 9篇 |
1983年 | 9篇 |
1982年 | 13篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 6篇 |
1975年 | 5篇 |
1974年 | 6篇 |
1970年 | 6篇 |
1969年 | 8篇 |
排序方式: 共有1618条查询结果,搜索用时 15 毫秒
21.
N. J. Crabtree N. A. Bebbington D. M. Chapman Y. S. Wahid J. Ayuk C. M. Boivin M. S. Cooper N. J. L. Gittoes 《Clinical endocrinology》2010,73(4):452-456
Objective To assess whether clinician‐determined treatment intervention thresholds are in line with the assessment of fracture risk provided by FRAX® and treatment recommendations provided by UK guidelines produced by the National Osteoporosis Guidelines Group (NOGG). Design, Patients and Measurements This was a retrospective cohort analysis of 288 patients consecutively referred for dual‐energy X‐ray absorptiometry (DXA) scanning from primary care immediately prior to the introduction of the FRAX® algorithm. In addition to DXA assessment, patients completed a clinical risk factor questionnaire which included risk factors used in the FRAX® algorithm. Initial risk assessment and treatment decisions were performed after DXA. FRAX® was used, retrospectively, with femoral neck T‐score, to estimate fracture risk which was applied to NOGG to generate guidance on treatment intervention. Clinician‐ and NOGG‐determined outcomes were audited for concordance. Results There was concordance between clinician and NOGG treatment decisions in 215 (74·6%) subjects. Discordance was observed in 73 (25·3%) subjects. In the discordant group, seven subjects were given lifestyle advice when NOGG recommended treatment, 42 given treatment when NOGG recommended lifestyle advice only, and 24 were referred to a metabolic bone clinic for further evaluation. The reasons for treatment differences in subjects recommended treatment by clinician but not NOGG were largely (90·2%) attributed to the use of lumbar spine bone mineral density (BMD). Conclusions There is high concordance between clinician‐determined and FRAX®‐NOGG intervention. The absence of spine BMD from FRAX® is the primary source of discrepancy. This study provides some assurance of the validity of the treatment thresholds generated from FRAX®‐NOGG in ‘real‐world’ usage. 相似文献
22.
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients 总被引:11,自引:0,他引:11
Boivin G Goyette N Gilbert C Roberts N Macey K Paya C Pescovitz MD Humar A Dominguez E Washburn K Blumberg E Alexander B Freeman R Heaton N Covington E 《The Journal of infectious diseases》2004,189(9):1615-1618
We investigated the emergence of cytomegalovirus (CMV) ganciclovir-resistance mutations in 301 high-risk solid-organ transplant (SOT) recipients after oral prophylaxis, for 100 days, with either valganciclovir or ganciclovir. For patients treated with ganciclovir, the incidence of CMV UL97 mutations was 1.9% (2/103) at the end of prophylaxis and 6.1% (2/33) for patients with suspected CMV disease up to 1 year after transplantation. No resistance mutations were detected in samples from valganciclovir-treated patients. Dual polymerase (UL54) and UL97 resistance mutations were not seen. Valganciclovir was associated with negligible risk of resistance and thus constitutes a useful alternative to ganciclovir prophylaxis for CMV in high-risk SOT recipients. 相似文献
23.
Drew D. DAngelo Yoshihito Sakata John N. Lorenz Gregory P. Boivin Richard A. Walsh Stephen B. Liggett Gerald W. Dorn II 《Proceedings of the National Academy of Sciences of the United States of America》1997,94(15):8121-8126
The critical cell signals that trigger cardiac hypertrophy and regulate the transition to heart failure are not known. To determine the role of Gαq-mediated signaling pathways in these events, transgenic mice were constructed that overexpressed wild-type Gαq in the heart using the α-myosin heavy chain promoter. Two-fold overexpression of Gαq showed no detectable effects, whereas 4-fold overexpression resulted in increased heart weight and myocyte size along with marked increases in atrial naturietic factor (≈55-fold), β-myosin heavy chain (≈8-fold), and α-skeletal actin (≈8-fold) expression, and decreased (≈3-fold) β-adrenergic receptor-stimulated adenylyl cyclase activity. All of these signals have been considered markers of hypertrophy or failure in other experimental systems or human heart failure. Echocardiography and in vivo cardiac hemodynamic studies indeed revealed impaired intrinsic contractility manifested as decreased fractional shortening (19 ± 2% vs. 41 ± 3%), dP/dt max, a negative force–frequency response, an altered Starling relationship, and blunted contractile responses to the β-adrenergic agonist dobutamine. At higher levels of Gαq overexpression, frank cardiac decompensation occurred in 3 of 6 animals with development of biventricular failure, pulmonary congestion, and death. The element within the pathway that appeared to be critical for these events was activation of protein kinase C. Interestingly, mitogen-activated protein kinase, which is postulated by some to be important in the hypertrophy program, was not activated. The Gαq overexpressor exhibits a biochemical and physiologic phenotype resembling both the compensated and decompensated phases of human cardiac hypertrophy and suggests a common mechanism for their pathogenesis. 相似文献
24.
Tiffany Lau Ian Y Wong Lawrence Iu Jay Chhablani Tao Yong Koizumi Hideki Jacky Lee Raymond Wong 《Indian journal of ophthalmology》2015,63(5):378-383
Optical coherence tomography (OCT) is a noninvasive imaging modality providing high-resolution images of the central retina that has completely transformed the field of ophthalmology. While traditional OCT has produced longitudinal cross-sectional images, advancements in data processing have led to the development of en-face OCT, which produces transverse images of retinal and choroidal layers at any specified depth. This offers additional benefit on top of longitudinal cross-sections because it provides an extensive overview of pathological structures in a single image. The aim of this review was to discuss the utility of en-face OCT in the diagnosis and management of age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV). En-face imaging of the inner segment/outer segment junction of retinal photoreceptors has been shown to be a useful indicator of visual acuity and a predictor of the extent of progression of geographic atrophy. En-face OCT has also enabled high-resolution analysis and quantification of pathological structures such as reticular pseudodrusen (RPD) and choroidal neovascularization, which have the potential to become useful markers for disease monitoring. En-face Doppler OCT enables subtle changes in the choroidal vasculature to be detected in eyes with RPD and AMD, which has significantly advanced our understanding of their pathogenesis. En-face Doppler OCT has also been shown to be useful for detecting the polypoid lesions and branching vascular networks diagnostic of PCV. It may therefore serve as a noninvasive alternative to fluorescein and indocyanine green angiography for the diagnosis of PCV and other forms of the exudative macular disease. 相似文献
25.
Tommy C. Y. Chan Tiffany W. S. Lau Jacky W. Y. Lee Ian Y. H. Wong Vishal Jhanji Raymond L. M. Wong 《Acta ophthalmologica. Supplement》2015,93(8):689-696
Collagen cross‐linking (CXL) with ultraviolet light‐activated riboflavin is a corneal surface procedure developed for the treatment of keratoconus and corneal ectasia. With the known microbicidal and corneal stiffening effects of ultraviolet irradiation and photoactivated riboflavin, it has recently been introduced for the management of infectious keratitis, especially for ulcers resistant to antimicrobial therapy or associated with corneal melting. Various authors have attempted to use CXL as an adjunctive, salvage or even as the sole treatment for infectious corneal ulcers. The aim of this review was to provide a summary of the clinical studies in the literature. It is worth noting that there is still no consensus on the treatment protocol of CXL against infectious keratitis. The disparities in outcome measures, treatment protocol and study design can confound the interpretation and hamper the generalization of the study results. Based on current evidence, the role of CXL in infectious keratitis remained unclear despite the reported success in some clinical cases. Further investigations are warranted concerning the efficacy and safety of treating infectious keratitis with CXL. 相似文献
26.
27.
Boivin G Lips P Ott SM Harper KD Sarkar S Pinette KV Meunier PJ 《The Journal of clinical endocrinology and metabolism》2003,88(9):4199-4205
Raloxifene has been shown to increase bone mineral density and reduce the risk of vertebral fracture in postmenopausal women with osteoporosis. In this study, we report the results of the first prospective longitudinal study to evaluate the mean degree of mineralization of bone (MDMB) in a group of patients enrolled in the Multiple Outcomes of Raloxifene Evaluation trial. Patients were randomly assigned to one of three treatment groups: placebo (n = 24), raloxifene 60 mg/d (RLX60; n = 22), or raloxifene 120 mg/d (RLX120; n = 18). All patients received daily calcium (500 mg) and vitamin D(3) (400-600 IU) supplementation for the duration of the study. Iliac crest biopsies were taken at baseline and after 2 yr of treatment. Quantitative microradiography was used to analyze the biopsy specimens and revealed a statistically significant (P < 0.05) mean percentage increase in total MDMB of 7.0, 5.3, and 5% for RLX60-, RLX120-, and placebo-treated patients, respectively, compared with baseline. Raloxifene treatment was found to shift the distribution of total bone mineral to higher values of MDMB (RLX60, 29%; RLX120, 8%) with greater heterogeneity, compared with placebo. The profile of MDMB observed in biopsies after treatment with placebo and raloxifene, compared with baseline, closely resembles physiological premenopausal bone. 相似文献
28.
29.
Kranzer K McGrath N Saul J Crampin AC Jahn A Malema S Mulawa D Fine PE Zaba B Glynn JR 《Tropical medicine & international health : TM & IH》2008,13(11):1341-1350
Objective To investigate individual, household and community factors associated with HIV test refusal in a counselling and testing programme offered at population level in rural Malawi. Methods HIV counselling and testing was offered to individuals aged 18–59 at their homes. Individual variables were collected by interviews and physical examinations. Household variables were determined as part of a previous census. Multivariate models allowing for household and community clustering were used to assess associations between HIV test refusal and explanatory variables. Results Of 2303 eligible adults, 2129 were found and 1443 agreed to HIV testing. Test refusal was less likely by those who were never married [adjusted odds ratio (aOR) 0.50 for men (95% CI 0.32; 0.80) and 0.44 (0.21; 0.91) for women] and by farmers [aOR 0.70 (0.52; 0.96) for men and 0.59 (0.40; 0.87) for women]. A 10% increase in cluster refusal rates increased the odds of refusal by 1.48 (1.32; 1.66) in men and 1.68 (1.32; 2.12) in women. Women counsellors increased the odds of refusal by 1.39 (1.00; 1.92) in men. Predictors of HIV test refusal in women were refusal of the husband as head of household [aOR 15.08 (9.39; 24.21)] and living close to the main road [aOR 6.07 (1.76; 20.98)]. Common reasons for refusal were fear of testing positive, previous HIV test, knowledge of HIV serostatus and the need for more time to think. Conclusion Successful VCT strategies need to encourage couples counselling and should involve participation of men and communities. 相似文献
30.
Cytomegalovirus (CMV) can be classified into 4 glycoprotein B (gB) genotypes, on the basis of sequence variation in the UL55 gene. We assessed the effect that CMV gB genotype has on virologic and clinical response to therapy, in 50 solid-organ-transplant recipients with CMV disease. CMV loads were determined at regular intervals after the start of therapy. Genotype results were correlated with CMV-load kinetics in response to therapy with ganciclovir. At the onset of treatment, the distribution of CMV gB genotypes was as follows: gB1, 19/50 (38%); gB2, 9/50 (18%); gB3, 12/50 (24%); gB4, 2/50 (4%); and mixed-genotype infection, 8/50 (16%). Between viral genotype groups, time to clearance of CMV, failure to clear CMV, and calculated CMV-load half-life after the start of therapy were not significantly different. The CMV gB genotype did not affect the rate of disease recurrence or occurrence of tissue-invasive disease. It appears that the gB genotype, which causes CMV disease, does not significantly influence CMV-load kinetics or clinical response to therapy. 相似文献